Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function

Autor: Emil Egecioglu, Britt G. Gabrielsson, Jörgen Isgaard, Mohammad Bohlooly-Y, Ole Skøtt, John J. Kopchick, Vilborg Palsdottir, Entela Bollano, Göran Bergström, Anna Wickman, Peter Bie, Irene J. Andersson
Rok vydání: 2007
Předmět:
medicine.medical_specialty
Nitric Oxide Synthase Type III
Physiology
Endocrinology
Diabetes and Metabolism

Nitric Oxide Synthase Type II
Aorta
Thoracic

Blood Pressure
Growth hormone receptor
Biology
Cardiovascular Physiology
Cardiovascular System
Plasma renin activity
Cardiovascular Physiological Phenomena
Electrocardiography
Mice
chemistry.chemical_compound
Enos
Physiology (medical)
Internal medicine
Renin
Renin–angiotensin system
Laron syndrome
medicine
Animals
RNA
Messenger

Receptor
Aldosterone
Mice
Knockout

Mice
Inbred BALB C

Reverse Transcriptase Polymerase Chain Reaction
Heart
Organ Size
Receptors
Somatotropin

medicine.disease
biology.organism_classification
Echocardiography
Doppler

Cardiovascular physiology
Endocrinology
chemistry
Potassium
Female
hormones
hormone substitutes
and hormone antagonists

Muscle Contraction
Zdroj: Egecioglu, E, Andersson, I J, Bollano, E, Palsdottir, V, Gabrielsson, B G, Kopchick, J J, Skøtt, O, Bie, P, Isgaard, J, Bohlooly-Y, M, Bergström, G & Wickman, A 2007, ' Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function ', American Journal of Physiology: Endocrinology and Metabolism, vol. 292, no. 5, pp. E1418-E1425 . https://doi.org/10.1152/ajpendo.00335.2006
ISSN: 1522-1555
0193-1849
Popis: To study the role of the growth hormone receptor (GHR) in the development of cardiovascular structure and function, female GHR gene-disrupted or knockout (KO) and wild-type (WT) mice at age 18 wk were used. GHR KO mice had lower plasma renin levels (12 ± 2 vs. 20 ± 4 mGU/ml, P < 0.05) and increased aortic endothelial NO synthase (eNOS) expression (146%, P < 0.05) accompanied by a 25% reduction in systolic blood pressure (BP, 110 ± 4 vs. 147 ± 3 mmHg, P < 0.001) compared with WT mice. Aldosterone levels were unchanged, whereas the plasma potassium concentration was elevated by 14% ( P < 0.05) in GHR KO. Relative left ventricular weight was 14% lower in GHR KO mice ( P < 0.05), and cardiac dimensions as analyzed by echocardiography were similarly reduced. Myograph studies revealed a reduced maximum contractile response in the aorta to norepinephrine (NE) and K+ ( P < 0.05), and aorta media thickness was decreased in GHR KO ( P < 0.05). However, contractile force was normal in mesenteric arteries, whereas sensitivity to NE was increased ( P < 0.05). Maximal acetylcholine-mediated dilatation was similar in WT and GHR KO mice, whereas the aorta of GHR KO mice showed an increased sensitivity to acetylcholine ( P < 0.05). In conclusion, loss of GHR leads to low BP and decreased levels of renin in plasma as well as increase in aortic eNOS expression. Furthermore, GHR deficiency causes functional and morphological changes in both heart and vasculature that are beyond the observed alterations in body size. These data suggest an important role for an intact GH/IGF-I axis in the maintenance of a normal cardiovascular system.
Databáze: OpenAIRE